Disease-Modifying Therapies in Parkinson's Disease

被引：0

作者：

Fabbri, Margherita ^{[1
]}

Corvol, Jean Christophe ^{[2
]}

Rascol, Olivier ^{[1
]}

机构：

[1] Univ Toulouse, CHU Toulouse, Toulouse NeuroToul Ctr Excellence Neurodegenerat C, Dept Clin Pharmacol & Neurosci,INSERM,Clin Invest, Toulouse, France

[2] Sorbonne Univ, Assistance Publ Hop Paris, Hop Pitie Salpetriere, Paris Brain Inst ICM,INSERM,CNRS,French NS Pk F CR, Paris, France

来源：

NEUROLOGIC CLINICS | 2025年 / 43卷 / 02期

关键词：

Disease modifying; Parkinson's disease; Clinical trials; Biomarkers; Outcomes; Platform trials; ALPHA-SYNUCLEIN; DOUBLE-BLIND; CLINICAL-TRIAL; PROGRESSION; SAFETY; TOLERABILITY; MULTICENTER; DEFICIENCY; LEVODOPA; EFFICACY;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：319 / 340

页数：22

共 87 条

[1] Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations [J].

Alcalay, Roy N. ;

Levy, Oren A. ;

Waters, Cheryl C. ;

Fahn, Stanley ;

Ford, Blair ;

Kuo, Sheng-Han ;

Mazzoni, Pietro ;

Pauciulo, Michael W. ;

Nichols, William C. ;

Gan-Or, Ziv ;

Rouleau, Guy A. ;

Chung, Wendy K. ;

Wolf, Pavlina ;

Oliva, Petra ;

Keutzer, Joan ;

Marder, Karen ;

Zhang, Xiaokui .

BRAIN, 2015, 138 :2648-2658

[2] The Impact of Type 2 Diabetes in Parkinson's Disease [J].

Athauda, Dilan ;

Evans, James ;

Wernick, Anna ;

Virdi, Gurvir ;

Choi, Minee L. ;

Lawton, Michael ;

Vijiaratnam, Nirosen ;

Girges, Christine ;

Ben-Shlomo, Yoav ;

Ismail, Khalida ;

Morris, Huw ;

Grosset, Donald ;

Foltynie, Thomas ;

Gandhi, Sonia .

MOVEMENT DISORDERS, 2022, 37 (08) :1612-1623

[3] Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial [J].

Athauda, Dilan ;

Maclagan, Kate ;

Skene, Simon S. ;

Bajwa-Joseph, Martha ;

Letchford, Dawn ;

Chowdhury, Kashfia ;

Hibbert, Steve ;

Budnik, Natalia ;

Zampedri, Luca ;

Dickson, John ;

Li, Yazhou ;

Aviles-Olmos, Iciar ;

Warner, Thomas T. ;

Limousin, Patricia ;

Lees, Andrew J. ;

Greig, Nigel H. ;

Tebbs, Susan ;

Foltynie, Thomas .

LANCET, 2017, 390 (10103) :1664-1675

[4] Impaired brain insulin signalling in Parkinson's disease [J].

Bassil, Fares ;

Delamarre, Anna ;

Canron, Marie-Helene ;

Dutheil, Nathalie ;

Vital, Anne ;

Negrier-Leibreich, Marie-Laure ;

Bezard, Erwan ;

Fernagut, Pierre-Olivier ;

Meissner, Wassilios G. .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (01)

[5] A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit [J].

Beal, M. Flint ;

Oakes, David ;

Shoulson, Ira ;

Henchcliffe, Claire ;

Galpern, Wendy R. ;

Haas, Richard ;

Juncos, Jorge L. ;

Nutt, John G. ;

Voss, Tiffini Smith ;

Ravina, Bernard ;

Shults, Clifford M. ;

Helles, Karen ;

Snively, Victoria ;

Lew, Mark F. ;

Griebner, Brian ;

Watts, Arthur ;

Gao, Shan ;

Pourcher, Emmanuelle ;

Bond, Louisette ;

Kompoliti, Katie ;

Agarwal, Pinky ;

Sia, Cherissa ;

Jog, Mandar ;

Cole, Linda ;

Sultana, Munira ;

Kurlan, Roger ;

Richard, Irene ;

Deeley, Cheryl ;

Waters, Cheryl H. ;

Figueroa, Angel ;

Arkun, Ani ;

Brodsky, Matthew ;

Ondo, William G. ;

Hunter, Christine B. ;

Jimenez-Shahed, Joohi ;

Palao, Alicia ;

Miyasaki, Janis M. ;

Julie, S. O. ;

Tetrud, James ;

Reys, Liza ;

Smith, Katharine ;

Singer, Carlos ;

Blenke, Anita ;

Russell, David S. ;

Cotto, Candace ;

Friedman, Joseph H. ;

Lannon, Margaret ;

Zhang, Lin ;

Drasby, Edward ;

Kumar, Rajeev .

JAMA NEUROLOGY, 2014, 71 (05) :543-552

[6] Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism [J].

Borsche, Max ;

Koenig, Inke R. ;

Delcambre, Sylvie ;

Petrucci, Simona ;

Balck, Alexander ;

Brueggemann, Norbert ;

Zimprich, Alexander ;

Wasner, Kobi ;

Pereira, Sandro L. ;

Avenali, Micol ;

Deuschle, Christian ;

Badanjak, Katja ;

Ghelfi, Jenny ;

Gasser, Thomas ;

Kasten, Meike ;

Rosenstiel, Philip ;

Lohmann, Katja ;

Brockmann, Kathrin ;

Valente, Enza Maria ;

Youle, Richard J. ;

Gruenewald, Anne ;

Klein, Christine .

BRAIN, 2020, 143 :3041-3051

[7] Basic Science Breaks Through: New Therapeutic Advances in Parkinson's Disease [J].

Brundin, Patrik ;

Atkin, Graham ;

Lamberts, Jennifer T. .

MOVEMENT DISORDERS, 2015, 30 (11) :1521-1527

[8] Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054 [J].

Brys, Miroslaw ;

Fanning, Laura ;

Hung, Serena ;

Ellenbogen, Aaron ;

Penner, Natalia ;

Yang, Minhua ;

Welch, Mackenzie ;

Koenig, Erica ;

David, Eric ;

Fox, Tara ;

Makh, Shavy ;

Aldred, Jason ;

Goodman, Ira ;

Pepinsky, Blake ;

Liu, YuTing ;

Graham, Danielle ;

Weihofen, Andreas ;

Cedarbaum, Jesse M. .

MOVEMENT DISORDERS, 2019, 34 (08) :1154-1163

[9] Immunotherapy in Parkinson's disease: Current status and future directions [J].

Chatterjee, Diptaman ;

Kordower, Jeffrey H. .

NEUROBIOLOGY OF DISEASE, 2019, 132

[10] Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design [J].

Cheng, Yi ;

Tan, Guohua ;

Zhu, Qihui ;

Wang, Chun ;

Ruan, Guangcong ;

Ying, Senhong ;

Qie, Jinlong ;

Hu, Xiaofei ;

Xiao, Zhifeng ;

Xu, Fenghua ;

Chen, Lu ;

Chen, Minjia ;

Pei, Yang ;

Zhang, Hao ;

Tian, Yuting ;

Chen, Dongfeng ;

Liu, Xingyin ;

Huang, Heqing ;

Wei, Yanling .

GUT MICROBES, 2023, 15 (02)

← 1 2 3 4 5 6 7 8 9 →